The one-step catalytic reduction of 4-nitrophenol using nanoparticles derived from the injection of metal salts leads to benchmark-setting turnover frequencies.
No takes yet. Share an insight, caveat, or question.
Menumerov et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: